Hamid Merchant

Pharmaceutical Scientist with ~20y experience in Product Development, Head of Bioscience at UEL, Deputy Editor-in-Chief @bjpharmacy

[Hamid Merchant @HamidMerchant]

Toxic/contaminated cough syrups have caused tragic incidents worldwide. To address this global health crisis, we present rapid, low-cost field assays for detecting ethylene glycol (EG) and diethylene glycol (DEG) in raw materials and medicinal syrups.
https://t.co/YGPTwGUksh

[Hamid Merchant @HamidMerchant]

England needs a phased national catch-up programme for #MenB to ensure equitable and effective protection for all adolescents. #Meningitis preventable deaths – even if few – are unacceptable when an effective vaccine exists.
@MeningitisNow @M_R_F @UKHSA
https://t.co/0bm3s7ZXXx

[Hamid Merchant @HamidMerchant]

#MenB is the cause of current outbreak in Kent. All cases in 15-19 years old in 2024/25 were also caused by MenB. Should NHS consider a MenB vaccine catchup program for adolescents who didn’t had it in their infancy? MenB was only introduced from 2015! #meningitis

[NHS @NHSuk]

Meningitis symptoms can develop quickly, so it’s important to act immediately if you spot them.

More info ➡️ https://t.co/FlXxJRTbqp

[Telegraph Global Health Security @TelGlobalHealth]

Number of children with high blood pressure around the world doubles in 20 years

Rising obesity seen as key to the rise of the ‘silent killer’ among those under 19

@benfarmerDT reports
https://t.co/ycKy1c18O6

[Hamid Merchant @HamidMerchant]

A consortium of multidisciplinary researchers pioneer tech that detects toxic cough syrups, aiming to protect vulnerable communities across the globe. @UEL_News
https://t.co/kFDuRQlUQN
https://t.co/W12lK8BwxP

[Hamid Merchant @HamidMerchant]

@EnnalsEthan

[Hamid Merchant @HamidMerchant]

NHS England invites 75–80-year-olds for their first respiratory syncytial virus (RSV) vaccine but not those in their 80s. In this article we provide a case for over 80s who are at the most risk from RSV among elderly. https://t.co/3zBJxGFQyz

[Hamid Merchant @HamidMerchant]

Offering vaccines to under-80’s for free on NHS, while asking over-80s to wait or take it privately, goes against the ethos of NHS. Why should not those in their 80s be included too?https://t.co/3zBJxGGoo7

[Hamid Merchant @HamidMerchant]

@NHSuk urged to offer free #RSV vaccine to over 80s
https://t.co/RbSFfwXBXy @UEL_News

[Hamid Merchant @HamidMerchant]

@UKHSA @ProfKevinFenton @AndyBurnhamGM @FPH @NHSEngland invites 75–80-year-olds for their first respiratory syncytial virus (#RSV) vaccine but not those in their 80s. In this article we provide a case for over 80s who are at the most risk from RSV among elderly. #UKHSA25
https://t.co/3zBJxGFQyz

[Hamid Merchant @HamidMerchant]

@UKHSA @NHSEngland invites 75–80-year-olds for their first respiratory syncytial virus (#RSV) vaccine but not those in their 80s. Why should not those in their 80s be included too? Over 80s are at the most risk from RSV associated hospitalisation among elderly.
https://t.co/3zBJxGFQyz

[Hamid Merchant @HamidMerchant]

@MZ_GOV_PL NHS England invites 75–80-year-olds for their first respiratory syncytial virus (RSV) vaccine but not those in their 80s. In this article we provide a case for over 80s who are at the most risk from RSV among elderly. https://t.co/3zBJxGFQyz

[Hamid Merchant @HamidMerchant]

@SagaUK @NHSEngland invites 75–80-year-olds for their first respiratory syncytial virus, #RSV vaccines – why should not those in their 80s be included too? Data from @UKHSA confirms that over 80s are most vulnerable to hospitalisation from RSV among elderly. https://t.co/hnbb5OOjhF

[Hamid Merchant @HamidMerchant]

@SagaUK @NHSEngland invites 75–80-year-olds for their first respiratory syncytial virus, #RSV vaccines – why should not those in their 80s be included too? Data from @UKHSA confirms that over 80s are most vulnerable to hospitalisation from RSV among elderly. https://t.co/hnbb5OOjhF

[Hamid Merchant @HamidMerchant]

@WHO @WHO_Europe @pahowho @WHOAFRO @WHOWPRO @WHOSEARO @WHOEMRO @PAHOCaribbean @WHOEgypt @WHOSouthAfrica @WHOThailand @NHSEngland invites 75–80-year-olds for their first respiratory syncytial virus, #RSV vaccines – why should not those in their 80s be included too? Data from @UKHSA confirms that over 80s are most vulnerable to hospitalisation from RSV among elderly. https://t.co/hnbb5OOjhF

[Hamid Merchant @HamidMerchant]

@NHS_NELondon @NHSEngland invites 75–80-year-olds for their first respiratory syncytial virus, #RSV vaccines – why should not those in their 80s be included too? Data from @UKHSA confirms that over 80s are most vulnerable to hospitalisation from RSV among elderly. https://t.co/hnbb5OOjhF

[Hamid Merchant @HamidMerchant]

@DrAlexaMM @ABC11_WTVD @GSK @NHSEngland invites 75–80-year-olds for their first respiratory syncytial virus, #RSV vaccines – why should not those in their 80s be included too? Data from @UKHSA confirms that over 80s are most vulnerable to hospitalisation from RSV among elderly. https://t.co/hnbb5OOjhF

[Hamid Merchant @HamidMerchant]

@CanadaAnimals @NHSEngland invites 75–80-year-olds for their first respiratory syncytial virus, #RSV vaccines – why should not those in their 80s be included too? Data from @UKHSA confirms that over 80s are most vulnerable to hospitalisation from RSV. https://t.co/hnbb5OOjhF

[Hamid Merchant @HamidMerchant]

@BambosMP @NHSEngland invites 75–80-year-olds for their first respiratory syncytial virus, #RSV vaccines – why should not those in their 80s be included too? Data from @UKHSA confirms that over 80s are most vulnerable to hospitalisation from RSV. https://t.co/hnbb5OOjhF

[Hamid Merchant @HamidMerchant]

@LungAssociation @NHSEngland invites 75–80-year-olds for their first respiratory syncytial virus, #RSV vaccines – why should not those in their 80s be included too? https://t.co/hnbb5OOjhF

[Hamid Merchant @HamidMerchant]

@CanPaedSociety @NHSEngland invites 75–80-year-olds for their first respiratory syncytial virus, #RSV vaccines – why should not those in their 80s be included too? https://t.co/hnbb5OOjhF